Richard Hoppe
Publication Details
-
Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome.
Arch Dermatol. 1995; (9): 1003-8
There are no large studies evaluating patients with erythrodermic mycosis fungoides and Sézary syndrome to determine the important prognostic factors that may influence survival. This is important since new treatment modalities have been proposed as superior to existing primary therapies. We performed a retrospective cohort study of 106 patients with erythrodermic mycosis fungoides and Sézary syndrome, followed up in the Stanford (Calif) Mycosis Fungoides Clinic, to define the important prognostic factors in this group.
Help
Internal